Company Overview and News
Chicago, IL – October 15, 2018 - Stocks in this week’s article include: WillScot Corp. (WSC - Free Report) , Primerica, Inc. (PRI - Free Report) , Bovie Medical Corp. (BVX - Free Report) , Shenandoah Telecommunications Co. (SHEN - Free Report) and Herbalife Nutrition Ltd. (HLF - Free Report) .
WFC WFCNP BVX SHEN HLF PRI VSH HEAR
The importance of new analyst coverage is evident from the extensive data it unearths for investors. Do analysts create value for companies by initiating coverage? Coverage initiation on a stock by analyst(s) is actually a sign of increased investor keenness. Investors on their part often assume there is something special in a stock to attract analysts’ attention. In other words, they believe that the company coming under the microscope definitely has some value.
CBSH HLF CBSHP BVX PRI CBCB SHEN
Alleghany Corporation (Y - Free Report) , which engages in property and casualty (P&C) reinsurance and insurance businesses, has been experiencing consistent improvement in revenues. This upside is mainly driven by higher investment income and noninsurance revenues. We expect this momentum to continue in the upcoming quarters, which in turn, will further accelerate the company’s growth. With gradual rise in interest rates, the insurer has been able to witness higher investment income in the past few quarters and we anticipate this trend to sustain in the near future.
PRI NAVG Y MKL
Estimates for Reinsurance Group of America, Incorporated (RGA - Free Report) have been revised upward over the past seven days, reflecting analysts’ confidence in the stock before earnings results. The stock has seen the Zacks Consensus Estimate for 2018 bottom line move 0.1% north to $11.29 and for 2019 being raised 0.2% to $13.30. This provider of traditional individual and group life, asset-intensive, critical illness and financial reinsurance carries an impressive VGM Scoreof B.
PRI ATH RGA
Horace Mann Educators Corporation (HMN - Free Report) and its units recently witnessed senior debt rating and insurance financial strength ratings (IFS) being upgraded by Moody’s Investors Service. The credit rating giant has raised the senior debt rating of Horace Mann to Baa2 from Baa3 while the IFS ratings of its property-casualty (P&C) units and Horace Mann Life Insurance Company have been upgraded to A2 from A3.
PRI NAVG HMN Y
A.M. Best has given a Long-Term Issue Credit Rating of “a-” to Torchmark Corporation’s (TMK - Free Report) $550 million 4.55% senior unsecured notes. These notes are scheduled to mature on Sep 15, 2028. The outlook is negative. The ratings came on the back of Torchmark’s multichannel distribution platform, diversified operations and a superior operational performance. The company sustainably has been generating solid revenues and delivering operating earnings across the majority of its core segments, thus leveraging its solid market position.
TMK 2454 PRI ATH TMK FG
2018-09-27 zacks - 1
Chicago, IL – September 27, 2018 - Stocks in this week’s article are Primerica, Inc. (PRI - Free Report) , Avaya Holdings Corp. (AVYA - Free Report) , Shenandoah Telecommunications Company (SHEN - Free Report) , DMC Global Inc. (BOOM - Free Report) and eXp World Holdings, Inc. (EXPI - Free Report)
GFN AVYA ELY GFNCP DNR PRI EXPI SAFM GFDV URBN GFNSL SHEN
Estimates for Sun Life Financial Inc. (SLF - Free Report) have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The stock has seen the Zacks Consensus Estimate for 2018 move 0.6% north to $3.57. Shares of this Zacks Rank #3 (Hold) life insurer have inched up 0.4% in a year against the industry’s decrease of 9.8%.
SLF PRI SLF ATH SLFYF SLF
Torchmark Corporation (TMK - Free Report) announced the pricing of $550 million aggregate principal amount of Senior Notes. The notes carry an interest rate of 4.550% and are scheduled to mature on Sep 15, 2028, subject to certain requirements. The aforementioned senior notes will pay interest on a semi-annual basis and become the company’s general unsecured senior obligations. The senior notes will be ranked junior to the life insurer’s secured indebtedness, if any, to the extent of the collateral securing such indebtedness.
TMK PRI NAVG TMK Y
Most investors trust research done by analysts to avoid inefficiencies triggered by lack of information. Thus, when it comes to coverage initiation, analysts naturally play a pivotal role. Coverage initiation by analyst(s) on a stock usually portrays higher investor inclination. Investors, on their part, often assume there is something special in a stock to attract analysts’ attention. In other words, they believe that the company coming under the microscope definitely has some value.
AVYA PRI EXPI SHEN
Estimates for Willis Towers Watson plc (WLTW - Free Report) have been revised upward by a cent over the past 30 days, reflecting analysts’ confidence in the stock. Shares of the company have slipped 1.5% year to date against its industry’s increase of 9.1%. The company remains well-poised for growth, banking on its operational efficiencies, investment in new growth avenues, strengthening of client services as well as a solid capital position.
KBH PRI ATH
Brighthouse Financial Inc. (BHF - Free Report) unveiled two products, namely the Brighthouse Fixed Rate Annuity and Brighthouse Fixed Rate Annuity MVA via Brighthouse Life Insurance Company. Shares of the company inched up 0.5% in the last trading session, given the company’s initiative to launch the fixed annuities for strengthening its product offering. This introduction of a couple of products is in tandem with the company’s intention of catering to financial advisors and clients with customized annuity and life insurance products.
BHF KBH PRI ATH
Lincoln National Corp.’s (LNC - Free Report) retail wealth management affiliate, Lincoln Financial Network (LFN), recently announced its agreement with BizEquity, the leading online provider of estimated business valuation big data across the globe. With this deal, Lincoln National and its independent advisors will be able to use BizEquity’s database of businesses and valuation information. Lincoln National’s expanding Strategic Alliances program is likely to benefit from this collaboration in a huge way.
WFC WFCNP ATH LNC PRI
Improving economy reflected by rising interest rates, a growing gross domestic product (GDP), favorable employment backdrop as well as the tax cut should keep the momentum alive for life insurers. Increasing interest rate has come as a boon to insurers with the Fed indicating two more hikes this year, lending an impression of aggressive rate increases. Despite life insurance companies having lowered exposure to interest-sensitive product lines, redesigning and re-pricing products, investment income still forms a major component of the top line.
TMK PRI ATH RGA TMK
Estimates for Manulife Financial Corporation (MFC - Free Report) have been revised upward over the past 30 days, reflecting analysts’ confidence in the stock. The stock has seen the Zacks Consensus Estimate for 2018 move nearly 1% north to $2.03 and for 2019, revised 0.5% upward to $2.19. Manulife Financial is one of the three dominant life insurers within its domestic Canadian market and possesses rapidly growing operations in the United States as well as across several Asian countries.
ATH MFC 0945 PRI MFC FG
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to PRI / Primerica, Inc. on message board site Silicon Investor.
as of ET